Global Advisory Committee on Vaccine Safety, 29-30 November 2006.
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine / Q000009:adverse effects / Q000592:standards; D002648:Child; D002675:Child, Preschool; D014943:Global Health; D020275:Guillain-Barre Syndrome / Q000209:etiology; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007194:India; D007223:Infant; D007252:Influenza Vaccines / Q000009:adverse effects / Q000592:standards; D022321:Japanese Encephalitis Vaccines / Q000009:adverse effects / Q000592:standards; D022401:Meningococcal Vaccines / Q000009:adverse effects; D009108:Mumps Vaccine / Q000009:adverse effects / Q000592:standards; D022242:Pneumococcal Vaccines / Q000009:adverse effects / Q000592:standards; D014612:Vaccines / Q000009:adverse effects / Q000592:standards*; D018074:Vaccines, Conjugate / Q000009:adverse effects; D014944:World Health Organization
D001500:BCG Vaccine; D007252:Influenza Vaccines; D022321:Japanese Encephalitis Vaccines; D022401:Meningococcal Vaccines; D009108:Mumps Vaccine; D022242:Pneumococcal Vaccines; D014612:Vaccines; D018074:Vaccines, Conjugate